Monday, February 13, 2012

Chart of the Day - Alexion Pharmaceuticals (ALXN)

The "Chart of the Day" is Alexion Pharmaceuticals (ALXN), which showed up on Thursday's Barchart "All Time High" list. Alexion on Thursday posted a new all-time high of $83.10 and closed up 4.85%. TrendSpotter has been Long since Dec 20 at $68.99. In recent news on the stock, Alexion on Thursday reported Q4 EPS of 41 cents, well above the consensus of 34 cents. Goldman Sachs on Feb 3 upgraded Alexion to Conviction Buy and raised the target to $91 from $83 citing high growth potential, an attractive drug portfolio, and status as a potential M&A buyout candidate. Alexion Pharmaceuticals, with a market cap of $14 billion, develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans.

alxn_700

No comments:

Post a Comment